Psychometric Properties of the Persian Multiple Sclerosis Vision Questionnaire in People With Multiple Sclerosis: A Cross-Sectional Study

IF 1.1 3区 医学 Q2 CLINICAL NEUROLOGY
Mohammad Mohammadi, Aysa Shaygannejad, Amirhosein Mahboubi Vand, Saeed Vaheb, Aynaz Mohammadi, Vahid Shaygannejad, Omid Mirmosayyeb
{"title":"Psychometric Properties of the Persian Multiple Sclerosis Vision Questionnaire in People With Multiple Sclerosis: A Cross-Sectional Study","authors":"Mohammad Mohammadi,&nbsp;Aysa Shaygannejad,&nbsp;Amirhosein Mahboubi Vand,&nbsp;Saeed Vaheb,&nbsp;Aynaz Mohammadi,&nbsp;Vahid Shaygannejad,&nbsp;Omid Mirmosayyeb","doi":"10.1155/ane/5660710","DOIUrl":null,"url":null,"abstract":"<div>\n \n <section>\n \n <h3> Background</h3>\n \n <p>Up to 80% of people with multiple sclerosis (PwMS) experience various visual symptoms. The MS Vision Questionnaire (MSVQ-7) is a self-report tool that assesses visual function in PwMS. This study is aimed at validating the MSVQ-7 in Persian-speaking PwMS and comparing its screening ability with the National Eye Institute Visual Function Questionnaire (NEI VFQ-25).</p>\n </section>\n \n <section>\n \n <h3> Materials and Methods</h3>\n \n <p>A total of 140 PwMS were enrolled in this study. All participants completed the MSVQ-7 (higher scores indicate worse visual symptoms) and the NEI VFQ-25 (lower scores indicate worse visual symptoms). Reliability was assessed using Cronbach′s alpha. Exploratory factor analysis (EFA) was used to evaluate the structural validity. To assess convergent validity, correlations between the MSVQ-7 and the NEI VFQ-25 were examined. Receiver operating characteristic (ROC) curve analysis was used to compare the MSVQ-7 and NEI VFQ-25 in classifying PwMS by optic neuritis (ON) history.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The Persian MSVQ-7 demonstrated excellent reliability (Cronbach<sup>′</sup>s alpha = 0.852). Test–retest reliability was excellent (ICC = 0.980; SEM = 0.65; MDC = 1.80), derived from the 63-participant retest subsample. The EFA revealed a unidimensional structure for the Persian MSVQ-7. There was a negative correlation between the MSVQ-7 and the NEI VFQ-25 (<i>r</i> = −0.72, <i>p</i> &lt; 0.001). The ROC curve analysis showed that the MSVQ-7 (AUC = 0.901, sensitivity = 98.3<i>%</i>, and specificity = 71.2<i>%</i>) had better screening ability than the NEI VFQ-25 (AUC = 0.826, sensitivity = 68.8<i>%</i>, and specificity = 83.3<i>%</i>) for classifying PwMS based on having ON history.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>MSVQ-7 is a valid and reliable patient-reported outcome measure in Persian PwMS. Its high sensitivity makes it an effective screening tool for assessment of visual function.</p>\n </section>\n </div>","PeriodicalId":6939,"journal":{"name":"Acta Neurologica Scandinavica","volume":"2026 1","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ane/5660710","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Neurologica Scandinavica","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/ane/5660710","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Up to 80% of people with multiple sclerosis (PwMS) experience various visual symptoms. The MS Vision Questionnaire (MSVQ-7) is a self-report tool that assesses visual function in PwMS. This study is aimed at validating the MSVQ-7 in Persian-speaking PwMS and comparing its screening ability with the National Eye Institute Visual Function Questionnaire (NEI VFQ-25).

Materials and Methods

A total of 140 PwMS were enrolled in this study. All participants completed the MSVQ-7 (higher scores indicate worse visual symptoms) and the NEI VFQ-25 (lower scores indicate worse visual symptoms). Reliability was assessed using Cronbach′s alpha. Exploratory factor analysis (EFA) was used to evaluate the structural validity. To assess convergent validity, correlations between the MSVQ-7 and the NEI VFQ-25 were examined. Receiver operating characteristic (ROC) curve analysis was used to compare the MSVQ-7 and NEI VFQ-25 in classifying PwMS by optic neuritis (ON) history.

Results

The Persian MSVQ-7 demonstrated excellent reliability (Cronbach′s alpha = 0.852). Test–retest reliability was excellent (ICC = 0.980; SEM = 0.65; MDC = 1.80), derived from the 63-participant retest subsample. The EFA revealed a unidimensional structure for the Persian MSVQ-7. There was a negative correlation between the MSVQ-7 and the NEI VFQ-25 (r = −0.72, p < 0.001). The ROC curve analysis showed that the MSVQ-7 (AUC = 0.901, sensitivity = 98.3%, and specificity = 71.2%) had better screening ability than the NEI VFQ-25 (AUC = 0.826, sensitivity = 68.8%, and specificity = 83.3%) for classifying PwMS based on having ON history.

Conclusion

MSVQ-7 is a valid and reliable patient-reported outcome measure in Persian PwMS. Its high sensitivity makes it an effective screening tool for assessment of visual function.

波斯多发性硬化症视力问卷在多发性硬化症患者中的心理测量特性:一项横断面研究
高达80%的多发性硬化症(PwMS)患者会出现各种视觉症状。MS视觉问卷(MSVQ-7)是一种评估PwMS视觉功能的自我报告工具。本研究旨在验证MSVQ-7在波斯语PwMS中的应用,并将其与美国国家眼科研究所视觉功能问卷(NEI VFQ-25)的筛查能力进行比较。材料与方法本研究共纳入140例PwMS。所有参与者都完成了MSVQ-7(得分越高表明视觉症状越差)和NEI VFQ-25(得分越低表明视觉症状越差)。采用Cronbach’s alpha评估信度。采用探索性因子分析(EFA)对结构效度进行评价。为了评估收敛效度,我们检验了MSVQ-7和NEI VFQ-25之间的相关性。采用受试者工作特征(ROC)曲线分析比较MSVQ-7和NEI VFQ-25对视神经炎(ON)病史对PwMS的分类。结果波斯MSVQ-7具有良好的信度(Cronbach’s alpha = 0.852)。重测信度极好(ICC = 0.980; SEM = 0.65; MDC = 1.80),来自63名参与者的重测子样本。EFA揭示了波斯MSVQ-7的一维结构。MSVQ-7与NEI VFQ-25呈负相关(r = - 0.72, p < 0.001)。ROC曲线分析显示,MSVQ-7 (AUC = 0.901,灵敏度= 98.3%,特异性= 71.2%)对有on病史的PwMS进行分类的筛查能力优于NEI VFQ-25 (AUC = 0.826,灵敏度= 68.8%,特异性= 83.3%)。结论MSVQ-7是波斯PwMS患者报告的有效、可靠的预后指标。它的高灵敏度使其成为评估视觉功能的有效筛选工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Neurologica Scandinavica
Acta Neurologica Scandinavica 医学-临床神经学
CiteScore
6.70
自引率
2.90%
发文量
161
审稿时长
4-8 weeks
期刊介绍: Acta Neurologica Scandinavica aims to publish manuscripts of a high scientific quality representing original clinical, diagnostic or experimental work in neuroscience. The journal''s scope is to act as an international forum for the dissemination of information advancing the science or practice of this subject area. Papers in English will be welcomed, especially those which bring new knowledge and observations from the application of therapies or techniques in the combating of a broad spectrum of neurological disease and neurodegenerative disorders. Relevant articles on the basic neurosciences will be published where they extend present understanding of such disorders. Priority will be given to review of topical subjects. Papers requiring rapid publication because of their significance and timeliness will be included as ''Clinical commentaries'' not exceeding two printed pages, as will ''Clinical commentaries'' of sufficient general interest. Debate within the speciality is encouraged in the form of ''Letters to the editor''. All submitted manuscripts falling within the overall scope of the journal will be assessed by suitably qualified referees.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书